Dogukan Akkus

Dr. Dogukan Akkus

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
GOGülten Çiçek Okuyan
Gülten Çiçek Okuyan
DADoğukan Akkuş
Doğukan Akkuş
Background: Exocrine pancreatic insufficiency (EPI) can be seen after bariatric/metabolic surgery. Fecal elastase level is a simple test in diagnosing and grading EPI. Quality of life changes in patients with bariatric/metabolic surgery related to gastrointestinal complaints is debated. Aim: This study aimed to investigate rates and grades of EPI via fecal elastase levels and association between EPI and quality of life in bariatric surgery patients. Methods: A prospective study was performed for patients with bariatric/metabolic surgery at their second-year follow-up. Fecal elastase levels were used to diagnose and grade EPI as severe or moderate. Patient’s gastrointestinal quality of life index (GIQLI) was calculated. Patients were grouped as sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), single-anastomosis sleeve ileal bypass (SASI), and transit bipartition (TB). Rates of severe or moderate EPI were primary outcome. Secondary outcome was an association between fecal elastase and GIQLI. Results: There were 17, 29, 21, and 15 patients in OAGB, SG, TB, and SASI groups. There was no significant difference between groups in GIQLI scores and fecal elastase levels (p = 0.152 and p = 0.361). Rates of patients with moderate EPI in the groups OAGB, SG, TB, and SASI were 23.5%, 17.2%, 14.3%, and 20.0%. GIQLI scores were not significantly correlated with age, postoperative morphometric data, and fecal elastase values (p > 0.05). Conclusion: Rates of patients with moderate EPI ranged from 14.3 to 23.5% at second-year follow-up. There was no patient with severe EPI. GIQLI scores were not significantly correlated with fecal elastase levels and different types of bariatric/metabolic surgery. Graphical

1 January 2023 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
EBEVREN BESLER
EVREN BESLER
ETEmre Teke
Emre Teke
DADoğukan Akkuş
Doğukan Akkuş
MDMahmut Hüdai Demir
Mahmut Hüdai Demir
SASebahat Aksaray
Sebahat Aksaray
MGMeryem Günay Gürleyik
Meryem Günay Gürleyik
Besler E, et al. Ann Surg Treat Res. 2023 Sep;105(3):165-171. https://doi.org/10.4174/astr.2023.105.3.165

26 May 2026 in Cancers
Verified
Journal Article
Open access
PDF file
DADogukan Akkus
Dogukan Akkus
EBEren Berber
Eren Berber
RPRafael Humberto Perez-Soto
Rafael Humberto Perez-Soto
Adrenal tumors are increasingly diagnosed due to widespread use of cross-sectional imaging and an aging population, making adrenalectomy a progressively more common surgical procedure. Over the past three decades, adrenal surgery has undergone a paradigm shift from open adrenalectomy to minimally invasive (MI) techniques, with laparoscopic adrenalectomy becoming the standard approach for most benign and selected malignant adrenal tumors. More recently, retroperitoneoscopic and robotic approaches have expanded the armamentarium available to adrenal surgeons, allowing for tailored, patient-specific surgical strategies. This review summarizes current evidence on MI adrenalectomy techniques, including transperitoneal and retroperitoneal laparoscopic approaches, hand-assisted adrenalectomy, and robotic adrenalectomy, with particular emphasis on their role in pheochromocytoma and adrenocortical carcinoma. In addition, evolving ancillary technologies such as laparoscopic ultrasound, indocyanine green fluorescence imaging, artificial intelligence, and virtual and augmented reality are reviewed, highlighting their potential to enhance intraoperative decision-making, safety, and surgical precision. Current controversies, including the role of preoperative alpha-blockade, partial versus total adrenalectomy in hereditary pheochromocytoma, the oncologic adequacy of MI surgery for adrenocortical carcinoma, and the selective use of lymph node dissection, are discussed. Available evidence supports MI adrenalectomy as a safe and effective approach in carefully selected patients when performed by experienced surgeons in high-volume centers. Technological innovations continue to refine surgical planning, execution, and training, suggesting that the future of adrenal surgery will increasingly rely on precision-guided, personalized, and data-driven strategies. This review offers a timely and comprehensive synthesis of the evolving landscape of MI adrenalectomy, uniquely integrating current evidence across the full spectrum of surgical techniques with a critical appraisal of emerging ancillary technologies while addressing unresolved clinical controversies relevant to contemporary surgical practice.

8 April 2026 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
DADogukan Akkus
Dogukan Akkus
BBBeren Berber
Beren Berber
RPRafael Humberto Pérez-Soto
Rafael Humberto Pérez-Soto
Backgrounds: Indocyanine green (ICG) is a fluorescent biocompatible dye that emits light in the near-infrared spectrum upon excitation, enabling real-time visualization of vascular anatomy and tissue perfusion during surgery. Its favorable safety profile and rapid pharmacokinetics have led to widespread adoption across surgical specialties. More recently, ICG fluorescence imaging has been utilized for tumor localization in adrenalectomy, improving intraoperative decision-making, particularly in complex anatomical regions. Methods: A comprehensive literature search was conducted using PubMed, EMBASE, and Google Scholar databases. Tailored search strategies were applied for each topic addressed in this review. Articles were considered eligible for inclusion if they met the following criteria: (1) original research studies, randomized controlled trials, or systematic reviews with or without meta-analysis; (2) studies involving human subjects; and (3) publications in the English language. All selected studies underwent independent review by 2 authors, and any discrepancies were resolved through discussion with a third reviewer. Results: ICG fluorescence imaging is a valuable adjunct for adrenal gland identification, as the adrenal cortex demonstrates strong fluorescence due to its rich vascularization, allowing clear differentiation from surrounding retroperitoneal tissue. Adrenocortical tumors typically exhibit a hyperfluorescent pattern, whereas medullary tumors and malignant lesions more commonly demonstrate hypofluorescence, likely reflecting differences in their underlying biochemical and anatomical characteristics. Furthermore, ICG is particularly useful in partial adrenalectomy for bilateral tumors, facilitating precise tumor localization and resection while preserving functional adrenal cortical tissue. Conclusions: ICG fluorescence imaging is a valuable adjunct in adrenal surgery, enabling real-time visualization of adrenal anatomy, vascular structures, and tissue perfusion. Its application improves gland identification, facilitates accurate tumor localization, and supports cortical-sparing approaches by preserving functional adrenal tissue.

18 August 2026 in The American Journal of Surgery
Verified
Journal Article
Open access
DADogukan Akkus
Dogukan Akkus
KHKamran Huseynli
Kamran Huseynli
AIArturan Ibrahimli
Arturan Ibrahimli
EMEdip Memisoglu
Edip Memisoglu
EBEren Berber
Eren Berber
Autofluorescence (AF) imaging helps identify parathyroid glands (PGs), while indocyanine green (ICG) imaging demonstrates perfusion. No device has historically provided both types of imaging interchangeably. Aim of this study is to assess the efficacy of a new device that provides both functions. This prospective study evaluated efficacy of a new fluorescence device that provides AF and ICG imaging in a combined fashion. 16 patients with 44 PGs were assessed. AF imaging after ICG injection was feasible in 98% of the time. While a satisfactory angiogragm was obtained in 78% of the time with ICG injection, a visual recognition of increase in fluorescence by the surgeon was challenging due to the grayscale imaging involved. Concurrent AF and ICG fluorescence imaging is possible with advances in optical engineering. However, perfusion assessment using the device based on human eye perception was challenging, suggesting the need for quantification.